-
1
-
-
0031577298
-
Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
-
Arai H., Morikawa Y., Higuchi M., Matsui T., Clark C.M., Miura M., Machida N., Lee V.M., Trojanowski J.Q., Sasaki H. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys. Res. Commun 1997, 236:262-264.
-
(1997)
Biochem. Biophys. Res. Commun
, vol.236
, pp. 262-264
-
-
Arai, H.1
Morikawa, Y.2
Higuchi, M.3
Matsui, T.4
Clark, C.M.5
Miura, M.6
Machida, N.7
Lee, V.M.8
Trojanowski, J.Q.9
Sasaki, H.10
-
2
-
-
0141738373
-
CSF markers for incipient Alzheimer's disease
-
Blennow K., Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003, 2:605-613.
-
(2003)
Lancet Neurol
, vol.2
, pp. 605-613
-
-
Blennow, K.1
Hampel, H.2
-
3
-
-
34247893817
-
Longitudinal stability of CSF biomarkers in Alzheimer's disease
-
Blennow K., Zetterberg H., Minthon L., Lannfelt L., Strid S., Annas P., Basun H., Andreasen N. Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci. Lett 2007, 419:18-22.
-
(2007)
Neurosci. Lett
, vol.419
, pp. 18-22
-
-
Blennow, K.1
Zetterberg, H.2
Minthon, L.3
Lannfelt, L.4
Strid, S.5
Annas, P.6
Basun, H.7
Andreasen, N.8
-
4
-
-
70349884191
-
CSF biomarker levels in early and late onset Alzheimer's disease
-
Bouwman F.H., Schoonenboom N.S., Verwey N.A., van Elk E.J., Kok A., Blankenstein M.A., Scheltens P., van der Flier W.M. CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol. Aging 2009, 30:1895-1901.
-
(2009)
Neurobiol. Aging
, vol.30
, pp. 1895-1901
-
-
Bouwman, F.H.1
Schoonenboom, N.S.2
Verwey, N.A.3
van Elk, E.J.4
Kok, A.5
Blankenstein, M.A.6
Scheltens, P.7
van der Flier, W.M.8
-
5
-
-
34548450659
-
Longitudinal changes of CSF biomarkers in memory clinic patients
-
Bouwman F.H., van der Flier W.M., Schoonenboom N.S., van Elk E.J., Kok A., Rijmen F., Blankenstein M.A., Scheltens P. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 2007, 69:1006-1011.
-
(2007)
Neurology
, vol.69
, pp. 1006-1011
-
-
Bouwman, F.H.1
van der Flier, W.M.2
Schoonenboom, N.S.3
van Elk, E.J.4
Kok, A.5
Rijmen, F.6
Blankenstein, M.A.7
Scheltens, P.8
-
6
-
-
33746642088
-
Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders
-
Bouwman F.H., van der Flier W.M., Schoonenboom N.S., van Elk E.J., Kok A., Scheltens P., Blankenstein M.A. Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders. Clin. Chem 2006, 52:1604-1606.
-
(2006)
Clin. Chem
, vol.52
, pp. 1604-1606
-
-
Bouwman, F.H.1
van der Flier, W.M.2
Schoonenboom, N.S.3
van Elk, E.J.4
Kok, A.5
Scheltens, P.6
Blankenstein, M.A.7
-
7
-
-
62349094208
-
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
-
Brys M., Pirraglia E., Rich K., Rolstad S., Mosconi L., Switalski R., Glodzik-Sobanska L., de S.S., Zinkowski R., Mehta P., Pratico D., Saint Louis L.A., Wallin A., Blennow K., de Leon M.J. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiol. Aging 2009, 30:682-690.
-
(2009)
Neurobiol. Aging
, vol.30
, pp. 682-690
-
-
Brys, M.1
Pirraglia, E.2
Rich, K.3
Rolstad, S.4
Mosconi, L.5
Switalski, R.6
Glodzik-Sobanska, L.7
de, S.S.8
Zinkowski, R.9
Mehta, P.10
Pratico, D.11
Saint Louis, L.A.12
Wallin, A.13
Blennow, K.14
de Leon, M.J.15
-
8
-
-
67650927663
-
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease
-
Buchhave P., Blennow K., Zetterberg H., Stomrud E., Londos E., Andreasen N., Minthon L., Hansson O. Longitudinal study of CSF biomarkers in patients with Alzheimer's disease. PLoS. One 2009, 4:e6294.
-
(2009)
PLoS. One
, vol.4
-
-
Buchhave, P.1
Blennow, K.2
Zetterberg, H.3
Stomrud, E.4
Londos, E.5
Andreasen, N.6
Minthon, L.7
Hansson, O.8
-
9
-
-
27744442197
-
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease
-
Buerger K., Otto M., Teipel S.J., Zinkowski R., Blennow K., DeBernardis J., Kerkman D., Schroder J., Schonknecht P., Cepek L., McCulloch C., Moller H.J., Wiltfang J., Kretzschmar H., Hampel H. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease. Neurobiol. Aging 2006, 27:10-15.
-
(2006)
Neurobiol. Aging
, vol.27
, pp. 10-15
-
-
Buerger, K.1
Otto, M.2
Teipel, S.J.3
Zinkowski, R.4
Blennow, K.5
DeBernardis, J.6
Kerkman, D.7
Schroder, J.8
Schonknecht, P.9
Cepek, L.10
McCulloch, C.11
Moller, H.J.12
Wiltfang, J.13
Kretzschmar, H.14
Hampel, H.15
-
10
-
-
35648937101
-
Current state and future directions of neurochemical biomarkers for Alzheimer's disease
-
de Jong D., Kremer B.P., Olde Rikkert M.G., Verbeek M.M. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin. Chem. Lab Med 2007, 45:1421-1434.
-
(2007)
Clin. Chem. Lab Med
, vol.45
, pp. 1421-1434
-
-
de Jong, D.1
Kremer, B.P.2
Olde Rikkert, M.G.3
Verbeek, M.M.4
-
11
-
-
37749016410
-
Longitudinal CSF isoprostane and MRI atrophy in the progression to AD
-
de Leon M.J., Mosconi L., Li J., de S.S., Yao Y., Tsui W.H., Pirraglia E., Rich K., Javier E., Brys M., Glodzik L., Switalski R., Saint Louis L.A., Pratico D. Longitudinal CSF isoprostane and MRI atrophy in the progression to AD. J. Neurol 2007, 254:1666-1675.
-
(2007)
J. Neurol
, vol.254
, pp. 1666-1675
-
-
de Leon, M.J.1
Mosconi, L.2
Li, J.3
de, S.S.4
Yao, Y.5
Tsui, W.H.6
Pirraglia, E.7
Rich, K.8
Javier, E.9
Brys, M.10
Glodzik, L.11
Switalski, R.12
Saint Louis, L.A.13
Pratico, D.14
-
12
-
-
0035910638
-
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
-
Hesse C., Rosengren L., Andreasen N., Davidsson P., Vanderstichele H., Vanmechelen E., Blennow K. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett 2001, 297:187-190.
-
(2001)
Neurosci. Lett
, vol.297
, pp. 187-190
-
-
Hesse, C.1
Rosengren, L.2
Andreasen, N.3
Davidsson, P.4
Vanderstichele, H.5
Vanmechelen, E.6
Blennow, K.7
-
13
-
-
0028169925
-
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43)
-
Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994, 13:45-53.
-
(1994)
Neuron
, vol.13
, pp. 45-53
-
-
Iwatsubo, T.1
Odaka, A.2
Suzuki, N.3
Mizusawa, H.4
Nukina, N.5
Ihara, Y.6
-
14
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010, 9:119-128.
-
(2010)
Lancet Neurol
, vol.9
, pp. 119-128
-
-
Jack, C.R.1
Knopman, D.S.2
Jagust, W.J.3
Shaw, L.M.4
Aisen, P.S.5
Weiner, M.W.6
Petersen, R.C.7
Trojanowski, J.Q.8
-
15
-
-
0033591203
-
Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease
-
Kanai M., Shizuka M., Urakami K., Matsubara E., Harigaya Y., Okamoto K., Shoji M. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease. Neurosci Lett 1999, 267:65-68.
-
(1999)
Neurosci Lett
, vol.267
, pp. 65-68
-
-
Kanai, M.1
Shizuka, M.2
Urakami, K.3
Matsubara, E.4
Harigaya, Y.5
Okamoto, K.6
Shoji, M.7
-
16
-
-
37749036105
-
Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques
-
Kumar-Singh S. Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques. Genes Brain Behav 2008, 1(7 Suppl):67-82.
-
(2008)
Genes Brain Behav
, vol.1
, Issue.7 SUPPL
, pp. 67-82
-
-
Kumar-Singh, S.1
-
17
-
-
34547890294
-
CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study
-
Li G., Sokal I., Quinn J.F., Leverenz J.B., Brodey M., Schellenberg G.D., Kaye J.A., Raskind M.A., Zhang J., Peskind E.R., Montine T.J. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology 2007, 69:631-639.
-
(2007)
Neurology
, vol.69
, pp. 631-639
-
-
Li, G.1
Sokal, I.2
Quinn, J.F.3
Leverenz, J.B.4
Brodey, M.5
Schellenberg, G.D.6
Kaye, J.A.7
Raskind, M.A.8
Zhang, J.9
Peskind, E.R.10
Montine, T.J.11
-
18
-
-
33144489150
-
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
-
McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del S.T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
-
(2005)
Neurology
, vol.65
, pp. 1863-1872
-
-
McKeith, I.G.1
Dickson, D.W.2
Lowe, J.3
Emre, M.4
O'Brien, J.T.5
Feldman, H.6
Cummings, J.7
Duda, J.E.8
Lippa, C.9
Perry, E.K.10
Aarsland, D.11
Arai, H.12
Ballard, C.G.13
Boeve, B.14
Burn, D.J.15
Costa, D.16
Del, S.T.17
Dubois, B.18
Galasko, D.19
Gauthier, S.20
Goetz, C.G.21
Gomez-Tortosa, E.22
Halliday, G.23
Hansen, L.A.24
Hardy, J.25
Iwatsubo, T.26
Kalaria, R.N.27
Kaufer, D.28
Kenny, R.A.29
Korczyn, A.30
Kosaka, K.31
Lee, V.M.32
Lees, A.33
Litvan, I.34
Londos, E.35
Lopez, O.L.36
Minoshima, S.37
Mizuno, Y.38
Molina, J.A.39
Mukaetova-Ladinska, E.B.40
Pasquier, F.41
Perry, R.H.42
Schulz, J.B.43
Trojanowski, J.Q.44
Yamada, M.45
more..
-
19
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
20
-
-
20944432380
-
Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease
-
Mollenhauer B., Bibl M., Trenkwalder C., Stiens G., Cepek L., Steinacker P., Ciesielczyk B., Neubert K., Wiltfang J., Kretzschmar H.A., Poser S., Otto M. Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease. J Neural Transm 2005, 112:933-948.
-
(2005)
J Neural Transm
, vol.112
, pp. 933-948
-
-
Mollenhauer, B.1
Bibl, M.2
Trenkwalder, C.3
Stiens, G.4
Cepek, L.5
Steinacker, P.6
Ciesielczyk, B.7
Neubert, K.8
Wiltfang, J.9
Kretzschmar, H.A.10
Poser, S.11
Otto, M.12
-
21
-
-
33645084250
-
Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease
-
Montine T.J., Quinn J.F., Montine K.S., Kaye J.A., Breitner J.C. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. J Alzheimers Dis 2005, 8:359-367.
-
(2005)
J Alzheimers Dis
, vol.8
, pp. 359-367
-
-
Montine, T.J.1
Quinn, J.F.2
Montine, K.S.3
Kaye, J.A.4
Breitner, J.C.5
-
22
-
-
0031672540
-
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria
-
Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
-
(1998)
Neurology
, vol.51
, pp. 1546-1554
-
-
Neary, D.1
Snowden, J.S.2
Gustafson, L.3
Passant, U.4
Stuss, D.5
Black, S.6
Freedman, M.7
Kertesz, A.8
Robert, P.H.9
Albert, M.10
Boone, K.11
Miller, B.L.12
Cummings, J.13
Benson, D.F.14
-
23
-
-
0142011171
-
Elevated neurofilament levels in neurological diseases
-
Norgren N., Rosengren L., Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Res 2003, 987:25-31.
-
(2003)
Brain Res
, vol.987
, pp. 25-31
-
-
Norgren, N.1
Rosengren, L.2
Stigbrand, T.3
-
24
-
-
8644272511
-
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
-
Norgren N., Sundstrom P., Svenningsson A., Rosengren L., Stigbrand T., Gunnarsson M. Neurofilament and glial fibrillary acidic protein in multiple sclerosis. Neurology 2004, 63:1586-1590.
-
(2004)
Neurology
, vol.63
, pp. 1586-1590
-
-
Norgren, N.1
Sundstrom, P.2
Svenningsson, A.3
Rosengren, L.4
Stigbrand, T.5
Gunnarsson, M.6
-
25
-
-
70350061949
-
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
-
Perrin R.J., Fagan A.M., Holtzman D.M. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009, 461:916-922.
-
(2009)
Nature
, vol.461
, pp. 916-922
-
-
Perrin, R.J.1
Fagan, A.M.2
Holtzman, D.M.3
-
26
-
-
0032988610
-
Mild cognitive impairment: clinical characterization and outcome
-
Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
-
(1999)
Arch Neurol
, vol.56
, pp. 303-308
-
-
Petersen, R.C.1
Smith, G.E.2
Waring, S.C.3
Ivnik, R.J.4
Tangalos, E.G.5
Kokmen, E.6
-
27
-
-
15944409728
-
Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss
-
Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005, 233:183-198.
-
(2005)
J Neurol Sci
, vol.233
, pp. 183-198
-
-
Petzold, A.1
-
28
-
-
33947710043
-
CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls
-
Pijnenburg Y.A., Janssen J.C., Schoonenboom N.S., Petzold A., Mulder C., Stigbrand T., Norgren N., Heijst H., Hack C.E., Scheltens P., Teunissen C.E. CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls. Dement Geriatr Cogn Disord 2007, 23:225-230.
-
(2007)
Dement Geriatr Cogn Disord
, vol.23
, pp. 225-230
-
-
Pijnenburg, Y.A.1
Janssen, J.C.2
Schoonenboom, N.S.3
Petzold, A.4
Mulder, C.5
Stigbrand, T.6
Norgren, N.7
Heijst, H.8
Hack, C.E.9
Scheltens, P.10
Teunissen, C.E.11
-
29
-
-
2342420034
-
Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
-
Pratico D., Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 2004, 6:171-175.
-
(2004)
J Alzheimers Dis
, vol.6
, pp. 171-175
-
-
Pratico, D.1
Sung, S.2
-
30
-
-
1842584884
-
Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease
-
Quinn J.F., Montine K.S., Moore M., Morrow J.D., Kaye J.A., Montine T.J. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. J Alzheimers Dis 2004, 6:93-97.
-
(2004)
J Alzheimers Dis
, vol.6
, pp. 93-97
-
-
Quinn, J.F.1
Montine, K.S.2
Moore, M.3
Morrow, J.D.4
Kaye, J.A.5
Montine, T.J.6
-
31
-
-
0037837209
-
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
-
Riemenschneider M., Wagenpfeil S., Vanderstichele H., Otto M., Wiltfang J., Kretzschmar H., Vanmechelen E., Forstl H., Kurz A. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 2003, 8:343-347.
-
(2003)
Mol Psychiatry
, vol.8
, pp. 343-347
-
-
Riemenschneider, M.1
Wagenpfeil, S.2
Vanderstichele, H.3
Otto, M.4
Wiltfang, J.5
Kretzschmar, H.6
Vanmechelen, E.7
Forstl, H.8
Kurz, A.9
-
32
-
-
48549106250
-
High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women
-
Roest M., Voorbij H.A.M., Van der Schouw Y.T., Peeters P.H.M., Teerlink T., Scheffer P.G. High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women. J Clin Lipidol 2008, 2:298-303.
-
(2008)
J Clin Lipidol
, vol.2
, pp. 298-303
-
-
Roest, M.1
Voorbij, H.A.M.2
Van der Schouw, Y.T.3
Peeters, P.H.M.4
Teerlink, T.5
Scheffer, P.G.6
-
33
-
-
0027534657
-
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
-
Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260.
-
(1993)
Neurology
, vol.43
, pp. 250-260
-
-
Román, G.C.1
Tatemichi, T.K.2
Erkinjuntti, T.3
Cummings, J.L.4
Masdeu, J.C.5
Garcia, J.H.6
Amaducci, L.7
Orgogozo, J.M.8
Brun, A.9
Hofman, A.10
-
34
-
-
67650348317
-
CSF biomarkers in relationship to cognitive profiles in Alzheimer disease
-
van der Vlies A.E., Verwey N.A., Bouwman F.H., Blankenstein M.A., Klein M., Scheltens P., van der Flier W.M. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. Neurology 2009, 72:1056-1061.
-
(2009)
Neurology
, vol.72
, pp. 1056-1061
-
-
van der Vlies, A.E.1
Verwey, N.A.2
Bouwman, F.H.3
Blankenstein, M.A.4
Klein, M.5
Scheltens, P.6
van der Flier, W.M.7
-
35
-
-
51849117288
-
Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements
-
Verwey N.A., Bouwman F.H., van der Flier W.M., Veerhuis R., Scheltens P., Blankenstein M.A. Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements. Clin Chem Lab Med 2008, 46:1300-1304.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 1300-1304
-
-
Verwey, N.A.1
Bouwman, F.H.2
van der Flier, W.M.3
Veerhuis, R.4
Scheltens, P.5
Blankenstein, M.A.6
-
36
-
-
68549094208
-
Quantification of amyloid-beta 40 in cerebrospinal fluid
-
Verwey N.A., Veerhuis R., Twaalfhoven H.A., Wouters D., Hoozemans J.J., Bollen Y.J., Killestein J., Bibl M., Wiltfang J., Hack C.E., Scheltens P., Blankenstein M.A. Quantification of amyloid-beta 40 in cerebrospinal fluid. J Immunol Methods 2009, 348:57-66.
-
(2009)
J Immunol Methods
, vol.348
, pp. 57-66
-
-
Verwey, N.A.1
Veerhuis, R.2
Twaalfhoven, H.A.3
Wouters, D.4
Hoozemans, J.J.5
Bollen, Y.J.6
Killestein, J.7
Bibl, M.8
Wiltfang, J.9
Hack, C.E.10
Scheltens, P.11
Blankenstein, M.A.12
-
37
-
-
70349159788
-
Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease
-
Zhou B., Teramukai S., Yoshimura K., Fukushima M. Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease. J Alzheimers Dis 2009, 18:89-102.
-
(2009)
J Alzheimers Dis
, vol.18
, pp. 89-102
-
-
Zhou, B.1
Teramukai, S.2
Yoshimura, K.3
Fukushima, M.4
|